Mr. Chair, I thank the member for Elmwood—Transcona for his comments. He has been a very strong advocate on this issue, as well.
I think if one takes the idea that this is not a crisis and needs to be addressed in the longer term, perhaps the government members would be justified in saying that the government has provided some funding, so that is all right.
However, we are not talking about some kind of research that is not addressing a chronic and serious health crisis. This is a chronic and serious health crisis, as the member for Elmwood—Transcona just mentioned. It is not something that one has to, or should, provide half-measures.
We must be moving forward with all haste, ensuring due diligence that this type of treatment and research requires. I believe there has to be a fine balance, but the government has to put in more resources, has to address it as a crisis, and has to assure Canadians, MS sufferers and their families that it is doing everything possible to address this as rapidly as possible.